LYTIR

Company · PVLA

Palvella Therapeutics, Inc.

Name as listed on its exchange; filed with the SEC as PALVELLA THERAPEUTICS, INC.

Nasdaq's symbol directory lists PVLA on Nasdaq as “Palvella Therapeutics, Inc. - Common Stock”.

In the 12 months to Nov 8, 2026: insiders sold on 12 occasions ($10.8M); 4 planned-sale notices; 6 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 22

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $10.8M in total.Jun: Insider sales $476KJul: Insider sales $642KAug: Insider sales $655KSep: Insider sales $4.9MOct: Insider sales $4.1MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $10.8M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. JENKINS GEORGE M sold on 6 days all under a 10b5-1 plan latest Oct 14, 2026 sold $7.7M
  2. Goin Kathleen, Chief Operating Officer sold on 5 days all under a 10b5-1 plan latest Oct 21, 2026 sold $3.0M
  3. KIRITSY CHRISTOPHER P sold on 1 day latest Sep 2, 2026 sold $49K
Every trade (12)
  1. SELLGoin Kathleen, Chief Operating Officer sold Oct 21, 2026 4,313 shares 3 legs combined 10b5-1 plan (scheduled) filing $537K
  2. SELLJENKINS GEORGE M sold Oct 14, 2026 7,174 shares 6 legs combined 10b5-1 plan (scheduled) filing $886K
  3. SELLJENKINS GEORGE M sold Oct 13, 2026 7,174 shares 6 legs combined 10b5-1 plan (scheduled) filing $935K
  4. SELLJENKINS GEORGE M sold Oct 12, 2026 13,152 shares 5 legs combined 10b5-1 plan (scheduled) filing $1.8M
  5. SELLGoin Kathleen, Chief Operating Officer sold Sep 16, 2026 4,302 shares 3 legs combined 10b5-1 plan (scheduled) filing $655K
  6. SELLJENKINS GEORGE M sold Sep 15, 2026 1,777 shares 3 legs combined 10b5-1 plan (scheduled) filing $267K
  7. SELLJENKINS GEORGE M sold Sep 14, 2026 13,352 shares 3 legs combined 10b5-1 plan (scheduled) filing $2.0M
  8. SELLJENKINS GEORGE M sold Sep 11, 2026 12,371 shares 3 legs combined 10b5-1 plan (scheduled) filing $1.9M
  9. SELLKIRITSY CHRISTOPHER P sold Sep 2, 2026 313 shares filing $49K
  10. SELLGoin Kathleen, Chief Operating Officer sold Aug 19, 2026 4,302 shares 5 legs combined 10b5-1 plan (scheduled) filing $655K
  11. SELLGoin Kathleen, Chief Operating Officer sold Jul 15, 2026 4,302 shares 4 legs combined 10b5-1 plan (scheduled) filing $642K
  12. SELLGoin Kathleen, Chief Operating Officer sold Jun 17, 2026 4,302 shares 3 legs combined 10b5-1 plan (scheduled) filing $476K

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Goin Kathleen filed Oct 21, 2026 Officer 4,313 shares planned sale date 10/21/2026 filing $534K
  2. JENKINS GEORGE M filed Oct 13, 2026 Director 27,500 shares planned sale date 10/13/2026 filing $3.7M
  3. Goin Kathleen filed Sep 16, 2026 Officer 4,302 shares planned sale date 09/16/2026 filing $651K
  4. JENKINS GEORGE M filed Sep 11, 2026 Director 27,500 shares planned sale date 09/11/2026 filing $4.1M

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Jennison Associates LLC filed Oct 28, 2026 Schedule 13G/A passive 1,101,652 shares filing 7.7%
  2. First Light Asset Management, LLC filed Aug 14, 2026 Schedule 13G/A passive filing 5.34%
  3. BIOTECHNOLOGY VALUE FUND L P filed Aug 14, 2026 Schedule 13G/A passive filing 4.7%
  4. PRUDENTIAL FINANCIAL INC filed Aug 10, 2026 Schedule 13G passive 962,374 shares filing 6.7%
  5. Jennison Associates LLC filed Aug 3, 2026 Schedule 13G passive 960,619 shares filing 6.7%
  6. BlackRock, Inc. filed Jul 29, 2026 Schedule 13G passive 812,953 shares filing 5.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Regulation FD disclosure filing Nov 5, 2026
  2. Other events filing Oct 28, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.